Challenges in Ultra-Cold Storage Vaccine Trials: Practical, Regulatory-Ready Solutions
Challenges in Ultra-Cold Storage Vaccine Trials: Practical, Regulatory-Ready Solutions Overcoming the Toughest Challenges in Ultra-Cold Storage Vaccine Trials Why Ultra-Cold Storage Complicates Trials (and What “Good” Looks Like) Ultra-cold products (≤−70 °C) are unforgiving. A brief rise above −60 °C can reduce lipid nanoparticle integrity or vector infectivity, and every additional handling step—airport X-ray holding, customs dwell,…
Read More “Challenges in Ultra-Cold Storage Vaccine Trials: Practical, Regulatory-Ready Solutions” »